Childhood Leukemia Treatment in Moradabad — Dr. Faran Naim, Hematology & Bone Marrow Transplant Specialist, Jigyasa Hospital
A childhood leukemia diagnosis is among the most frightening moments a parent can face — but it's important for families to know that leukemia in children, particularly the most common form, has some of the highest treatment success rates of any childhood cancer.
At Jigyasa Hospital, Dr. Faran Naim, our Hematology & Bone Marrow Transplant specialist, provides diagnosis, treatment planning, and ongoing care for children with leukemia in Moradabad, giving families access to expert hematology-oncology management close to home throughout what is often a long and demanding treatment journey.
What Is Childhood Leukemia?
Leukemia is a cancer of the blood-forming cells, typically originating in the bone marrow, where abnormal white blood cells multiply uncontrollably and crowd out the normal production of healthy blood cells. In children, leukemia is the most common type of childhood cancer overall.
Acute Lymphoblastic Leukemia (ALL)
The most common form of leukemia in children, arising from immature lymphocyte precursor cells. It typically develops and progresses rapidly, requiring prompt treatment, but also has among the best treatment outcomes of any childhood cancer with modern therapy.
Acute Myeloid Leukemia (AML)
Less common than ALL in children but still a significant cause of childhood leukemia, arising from myeloid precursor cells. AML generally requires a different and often more intensive treatment approach than ALL.
Chronic Leukemias
Much rarer in children than in adults, but chronic myeloid leukemia can occur in the pediatric age group and is managed differently from the acute forms.
Because ALL and AML behave differently and respond to different treatment protocols, accurately distinguishing between them — and further subtyping within each category — is a critical first step in planning treatment.
Symptoms of Childhood Leukemia
Leukemia symptoms in children often develop over days to a few weeks and can resemble common childhood illnesses at first, which is one reason diagnosis sometimes takes a bit of time. Signs to watch for include:
- • Persistent fatigue and unusual paleness
- • Frequent or unusual infections, or infections that don't respond well to standard treatment
- • Easy bruising or unusual bleeding, including nosebleeds or bleeding gums
- • Bone or joint pain, sometimes causing a limp or reluctance to walk
- • Persistent, unexplained fever
- • Swollen lymph nodes in the neck, armpit, or groin
- • Abdominal swelling or discomfort, related to an enlarged liver or spleen
- • Loss of appetite and unintentional weight loss
- • Small red or purple spots on the skin (petechiae)
- • General irritability or reduced activity level, particularly in younger children
Because many of these symptoms overlap with common childhood infections, a combination of persistent or worsening symptoms — rather than any single sign alone — is usually what prompts further evaluation with blood tests.
How Childhood Leukemia Is Diagnosed
Dr. Naim follows a structured diagnostic pathway to confirm leukemia, identify its specific type, and assess risk category:
Complete Blood Count (CBC)
Often the first clue, typically showing abnormal white blood cell counts along with low red blood cells and platelets, reflecting the bone marrow's normal function being crowded out. Processed through the hospital's NABL-accredited laboratory.
Peripheral Blood Smear
Examination of blood cells under the microscope, which can reveal abnormal immature cells (blasts) suggestive of leukemia.
Bone Marrow Aspiration and Biopsy
The definitive diagnostic test, confirming the presence and percentage of leukemic blast cells in the marrow and allowing further characterization of the leukemia type.
Immunophenotyping
A laboratory technique that identifies specific markers on the surface of leukemia cells, essential for distinguishing ALL from AML and further classifying subtypes within each.
Cytogenetic and Molecular Testing
Performed on bone marrow samples to identify specific genetic changes within the leukemia cells, which carry important prognostic information and, in some cases, directly influence treatment choices.
Lumbar Puncture (Spinal Tap)
Performed to check whether leukemia cells have spread to the central nervous system (brain and spinal cord fluid), which is common enough in childhood leukemia that it's routinely checked and, when needed, specifically treated as part of the overall protocol.
Imaging Studies
Chest X-ray or other imaging may be used to assess for an enlarged thymus or other findings relevant to certain leukemia subtypes.
Risk Stratification
Based on the child's age, white blood cell count at diagnosis, leukemia subtype, and genetic findings, children with ALL are classified into risk categories (such as standard-risk, high-risk) that directly shape the intensity of treatment recommended.
How Childhood Leukemia Is Treated
Childhood leukemia treatment, particularly for ALL, follows a structured, multi-phase protocol developed and refined over decades of research, generally including the following phases:
Induction Therapy
The first, intensive phase of treatment, typically lasting about four to six weeks, aimed at rapidly destroying the majority of leukemia cells and achieving remission — meaning no detectable leukemia cells in the bone marrow by standard testing.
Consolidation (Intensification) Therapy
Following successful induction, this phase uses additional chemotherapy to eliminate any remaining leukemia cells not detectable by routine testing, reducing the risk of relapse.
Central Nervous System-Directed Therapy
Since leukemia cells can hide in the central nervous system where standard chemotherapy doesn't penetrate as effectively, specific treatment — often chemotherapy given directly into the spinal fluid — is used throughout treatment to prevent or treat central nervous system involvement.
Maintenance Therapy
A longer phase, often lasting one to two years for ALL, using lower-intensity chemotherapy, frequently including oral medications, to keep the leukemia in remission over the long term.
Treatment for AML
Generally more intensive than ALL treatment overall, typically involving more concentrated chemotherapy cycles over a shorter overall timeline, and stem cell transplant is considered more frequently as part of the treatment plan for certain AML subtypes or risk categories.
Stem Cell Transplant for High-Risk or Relapsed Disease
For children with high-risk leukemia features, poor response to initial treatment, or relapsed disease, allogeneic stem cell transplant may be recommended as part of the treatment plan. Dr. Naim evaluates transplant candidacy, coordinates HLA typing of siblings, and manages the referral and follow-up care pathway.
Supportive Care Throughout Treatment
Including management of low blood counts, infection prevention and prompt treatment, nutritional support, and psychosocial support for the child and family throughout the treatment course.
What Families Can Expect During Treatment
Childhood leukemia treatment, particularly for ALL, typically spans two to three years from diagnosis through the end of maintenance therapy, though the most intensive periods are concentrated in the earlier months. Regular blood tests, periodic bone marrow reassessment, and close monitoring for side effects are built into the protocol throughout. Many children are able to attend school and participate in normal activities during the maintenance phase, with adjustments made around treatment visits and periods of lower blood counts. Family involvement — understanding the treatment schedule, recognizing warning signs of infection or other complications, and maintaining consistency with medication schedules during maintenance therapy — plays an important role in successful treatment.
Long-Term Follow-Up After Treatment
Once treatment is completed, children continue to be monitored regularly to watch for signs of relapse and to check for any long-term effects of treatment on growth, organ function, or other aspects of health. This long-term follow-up typically continues for years after treatment ends, with visits becoming less frequent over time as the risk of relapse decreases.
Structured, Protocol-Based Treatment
Dr. Naim manages childhood leukemia treatment according to established, evidence-based multi-phase protocols, ensuring children receive treatment aligned with current standards of care.
Comprehensive Diagnostic Capability
From initial blood counts to bone marrow examination and specialized testing, Jigyasa Hospital's NABL-accredited laboratory supports the detailed diagnostic workup childhood leukemia requires.
Coordinated, Continuous Care
From diagnosis through induction, consolidation, maintenance, and long-term follow-up — and coordinated transplant referral when needed — Dr. Naim provides continuity throughout a long treatment journey, reducing the burden of fragmented care across multiple centers.
24/7 Emergency Care
Children undergoing leukemia treatment are at heightened risk of infection and other urgent complications, particularly during periods of low blood counts. Jigyasa Hospital's round-the-clock emergency services ensure prompt care when needed.
Trusted Childhood Leukemia Care in Moradabad
Patients from Moradabad, Rampur, Sambhal, Amroha, Bijnor, and nearby districts choose Jigyasa Hospital for specialist pediatric leukemia care, NABL lab, PM-JAY empanelment, and comprehensive support.
Why Choose Jigyasa Hospital for Childhood Leukemia Care
Childhood leukemia treatment is a marathon, not a sprint, and having a trusted, experienced care team makes a meaningful difference. Jigyasa Hospital, located on Rampur Road near Miglani Cinema, Moradabad, offers comprehensive childhood leukemia care under Dr. Faran Naim, keeping as much of the journey as possible close to the patient home and family.
- • Structured, Protocol-Based Treatment: Dr. Naim manages childhood leukemia treatment according to established, evidence-based multi-phase protocols, ensuring children receive treatment aligned with current standards of care.
- • Comprehensive Diagnostic Capability: From initial blood counts to bone marrow examination and specialized testing, Jigyasa Hospital's NABL-accredited laboratory supports the detailed diagnostic workup childhood leukemia requires.
- • Coordinated, Continuous Care: From diagnosis through induction, consolidation, maintenance, and long-term follow-up — and coordinated transplant referral when needed — Dr. Naim provides continuity throughout a long treatment journey, reducing the burden of fragmented care across multiple centers.
- • Ayushman Bharat PM-JAY Empanelment: Childhood leukemia treatment is intensive and prolonged. PM-JAY empanelment at Jigyasa Hospital helps make this care more accessible to eligible families.
- • 24/7 Emergency Care: Children undergoing leukemia treatment are at heightened risk of infection and other urgent complications, particularly during periods of low blood counts. Jigyasa Hospital's round-the-clock emergency services ensure prompt care when needed.
Book an Appointment with Dr. Faran Naim
Jigyasa Hospital offers specialist hematology and childhood leukemia care under the guidance of Dr. Faran Naim. From accurate diagnosis and individualized treatment planning to supportive care and long-term follow-up, comprehensive care is available close to home.
Near Miglani Cinema, Rampur Road, Moradabad 244001
Call Now
7900903333Frequently Asked Questions
Is childhood leukemia curable?
Many children with acute lymphoblastic leukemia (ALL), the most common childhood leukemia, achieve long-term cure with modern treatment protocols. Acute myeloid leukemia (AML) is generally more challenging to treat but is also managed with structured, intensive protocols aimed at long-term remission.
How long does childhood leukemia treatment take?
Treatment for ALL typically spans about two to three years, including an intensive initial phase followed by a longer maintenance period. AML treatment is generally shorter in overall duration but more intensive during the treatment period itself.
Why is a lumbar puncture done in childhood leukemia?
A lumbar puncture checks whether leukemia cells have spread to the central nervous system and allows delivery of chemotherapy directly into the spinal fluid, since standard chemotherapy doesn't reach this area as effectively.
What are the early warning signs of leukemia in a child?
Persistent fatigue, unusual paleness, frequent infections, easy bruising or bleeding, bone or joint pain, unexplained fever, and swollen lymph nodes are all signs that, especially in combination, warrant a prompt blood test evaluation.
Does every child with leukemia need a bone marrow transplant?
No. Most children with standard-risk ALL are treated successfully with chemotherapy alone. Stem cell transplant is generally reserved for high-risk leukemia features, poor response to initial treatment, relapsed disease, or certain AML subtypes.
Can a child continue going to school during leukemia treatment?
Many children are able to attend school, particularly during the maintenance phase of treatment, with adjustments made around treatment visits and periods of increased infection risk, in coordination with the care team.
What is remission, and how is it confirmed?
Remission means no detectable leukemia cells are found in the bone marrow using standard testing, typically assessed after the induction phase of treatment through a follow-up bone marrow examination.
How often does a child need follow-up after finishing leukemia treatment?
Follow-up is typically frequent in the first months to years after completing treatment, focusing on relapse monitoring and assessing for any long-term effects, gradually becoming less frequent over time as risk decreases.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001